Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
July 25, 2021
White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, et al.
Journal for Immunotherapy of Cancer
|
January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial
Kelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2020
ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma
Yuta Myojin, Takahiro Kodama, Kazuki Maesaka, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
March 31, 2021
Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis
Naoki Mizutani, Hayato Hikita, Yoshinobu Saito, et al.
Gastroenterology
|
December 21, 2020
Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production
Yuta Myojin, Hayato Hikita, Masaya Sugiyama, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 4, 2025
Liver Sinusoidal Endothelial Cells Promote Metabolic Dysfunction-associated Steatohepatitis Progression via Interleukin-1R1-mediated Chemokine Production Induced by Macrophage-derived Interleukin-1β
Kenji Fukumoto, Hayato Hikita, Yoshinobu Saito, et al.
Cancer Science
|
September 8, 2022
Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss
Katsuhiko Sato, Hayato Hikita, Minoru Shigekawa, et al.
Cancers
|
February 25, 2022
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma
Akira Nishio, Takahiro Kodama, Kazuma Daiku, et al.
Cancers
|
January 21, 2023
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Cellular and Molecular Gastroenterology and Hepatology
|
July 25, 2021
White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, et al.
Journal for Immunotherapy of Cancer
|
January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial
Kelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2020
ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma
Yuta Myojin, Takahiro Kodama, Kazuki Maesaka, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
March 31, 2021
Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis
Naoki Mizutani, Hayato Hikita, Yoshinobu Saito, et al.
Gastroenterology
|
December 21, 2020
Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production
Yuta Myojin, Hayato Hikita, Masaya Sugiyama, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 4, 2025
Liver Sinusoidal Endothelial Cells Promote Metabolic Dysfunction-associated Steatohepatitis Progression via Interleukin-1R1-mediated Chemokine Production Induced by Macrophage-derived Interleukin-1β
Kenji Fukumoto, Hayato Hikita, Yoshinobu Saito, et al.
Cancer Science
|
September 8, 2022
Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss
Katsuhiko Sato, Hayato Hikita, Minoru Shigekawa, et al.
Cancers
|
February 25, 2022
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy
Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma
Akira Nishio, Takahiro Kodama, Kazuma Daiku, et al.
Cancers
|
January 21, 2023
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, et al.
Page
of 4